PSI CRO, Zug, Switzerland, 1 August 2018 – PSI CRO has announced opening offices in Bangalore, India at, 24, Vittal Mallya Road, Bangalore, 5600.
“We are very excited about our new location in Bangalore, India,” says Radhika Bobba, Regional Director of India and Far East operations. “We are excited about PSI’s growth in India and remain loyal to our commitment to on-time delivery of high-quality clinical trials. India has a great potential to speed up many global trials and PSI employees are experts at that.”
Before that, in 2017, PSI opened offices in Sydney, Australia, and Seoul, South Korea. Since its inception in 1995, PSI has remained a private company fully owned by its management and has grown organically to include more than 50 locations and 2,000+ employees globally.
About PSI: PSI is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and is known to be highly selective about the work that they pursue. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is on a mission to be the best CRO in the world as measured by its employees, customers, study sites, and vendors.
Global headquarters are located in Switzerland at 113a Baarerstrasse, 6300 Zug.
PSI Inquires to:
Kayt Leonard
Kayt.Leonard@psi-cro.com